Arne Svejgaard

Active 1968–2015

81
Papers
18,297
Citations
78
h-index
81
i10-index

Citations

Citations per year for Arne Svejgaard1969: 1 citations1970: 3 citations1971: 1 citations1972: 1 citations1973: 3 citations1974: 21 citations1975: 30 citations1976: 27 citations1977: 30 citations1978: 22 citations1979: 24 citations1980: 31 citations1981: 34 citations1982: 21 citations1983: 35 citations1984: 28 citations1985: 22 citations1986: 33 citations1987: 27 citations1988: 30 citations1989: 29 citations1990: 27 citations1991: 44 citations1992: 61 citations1993: 63 citations1994: 71 citations1995: 77 citations1996: 55 citations1997: 84 citations1998: 121 citations1999: 127 citations2000: 144 citations2001: 181 citations2002: 201 citations2003: 172 citations2004: 202 citations2005: 200 citations2006: 143 citations2007: 105 citations2008: 140 citations2009: 114 citations2010: 87 citations2011: 67 citations2012: 64 citations2013: 47 citations2014: 46 citations2015: 61 citations2016: 39 citations2017: 29 citations2018: 39 citations2019: 105 citations2020: 98 citations2021: 114 citations2022: 68 citations2023: 46 citations2024: 70 citations2025: 27 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,224 citing papers, 29.2% of this breakdownUnited Kingdom: 522 citing papers, 12.5% of this breakdownGermany: 254 citing papers, 6.1% of this breakdownDenmark: 253 citing papers, 6% of this breakdownNetherlands: 160 citing papers, 3.8% of this breakdownSweden: 144 citing papers, 3.4% of this breakdownCanada: 142 citing papers, 3.4% of this breakdownAustralia: 139 citing papers, 3.3% of this breakdownFrance: 135 citing papers, 3.2% of this breakdownItaly: 132 citing papers, 3.1% of this breakdownJapan: 112 citing papers, 2.7% of this breakdownSwitzerland: 92 citing papers, 2.2% of this breakdown
0%29.2%Other 21.1%

Fields

  • Medicine47.3%
  • Immunology and Microbiology31%
  • Biochemistry, Genetics and Molecular Biology16.2%
  • Neuroscience2%
  • Dentistry1.8%
  • Agricultural and Biological Sciences0.6%
  • Other1.1%

Topics

  • T-cell and B-cell Immunology8.6%
  • Immune Cell Function and Interaction6.1%
  • Immunotherapy and Immune Responses4.3%
  • Diabetes and associated disorders4.2%
  • Multiple Sclerosis Research Studies3%
  • Complement system in diseases2.8%
  • Other71%

Coauthors

All papers

Open in search
  1. A functional and structural basis for TCR cross-reactivity in multiple sclerosis

    Authors: , , , , , , , , , , , , , - Nature Immunology 2002 cited by 594

  2. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor

    Authors: , , , , , , , , , , , - Nature Genetics 1999 cited by 334

  3. HL-A ANTIGENS AND DIABETES MELLITUS

    Authors: , , , , , , , , , - The Lancet 1974 cited by 814

  4. Mice lacking all conventional MHC class II genes

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 332

  5. Constitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease

    Authors: , , , , , , , , - Journal of Biological Chemistry 2003 cited by 196

  6. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: Tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 226

  7. Visualization of Myelin Basic Protein (Mbp) T Cell Epitopes in Multiple Sclerosis Lesions Using a Monoclonal Antibody Specific for the Human Histocompatibility Leukocyte Antigen (Hla)-Dr2–Mbp 85–99 Complex

    Authors: , , , , , , , , , - The Journal of Experimental Medicine 2000 cited by 197

  8. Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 152

  9. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein

    Authors: , , , , , , - The Journal of Immunology 1995 cited by 762

  10. Nomenclature for factors of the HLA system, 1998

    Authors: , , , , , , , , , , , , , , , , - Tissue Antigens 1999 cited by 263

  11. Nomenclature for Factors of the HLA system, 1990

    Authors: , , , , , , , , , , , , , - Tissue Antigens 1991 cited by 220

  12. Nomenclature for factors of the HLA system, 2002

    Authors: , , , , , , , , , , , , , , , - Tissue Antigens 2002 cited by 186

  13. Association of mannose-binding-lectin deficiency with severe atherosclerosis

    Authors: , , , , - The Lancet 1998 cited by 159

  14. Nomenclature for factors of the HLA system, 1989

    Authors: , , , , , , , , , , , , , - Tissue Antigens 1990 cited by 131

  15. Human retinal pigment epithelial cell-induced apoptosis in activated T cells.

    Authors: , , , , , , , , , , , , - 1998 cited by 105

  16. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256 – 270 glycopeptide to H-2Aq and H-2Ap molecules

    Authors: , , , , , , , , , , - European Journal of Immunology 1998 cited by 90

  17. Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins

    Authors: , , , , , , , , , , - Blood 2006 cited by 79

  18. HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS, WITH SPECIAL REFERENCE TO CLINICAL COURSE

    Authors: , , , , , - The Lancet 1973 cited by 473

  19. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin

    Authors: , , , , , , - The Lancet 1997 cited by 353

  20. Nomenclature for factors of the HLA system, 1991

    Authors: , , , , , , , , , , , , , - Tissue Antigens 1992 cited by 339

  21. HL-A ANTIGENS AND MULTIPLE SCLEROSIS

    Authors: , , - The Lancet 1972 cited by 317

  22. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals

    Authors: , , , , , , , , , , , , , - AIDS 1997 cited by 237

  23. Strong combined gene–environment effects in anti–cyclic citrullinated peptide–positive rheumatoid arthritis: A nationwide case–control study in Denmark

    Authors: , , , , , , , , - Arthritis & Rheumatism 2007 cited by 201

  24. Reconstitution in Severe Combined Immunodeficiency by Transplantation of Marrow from an Unrelated Donor

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 1977 cited by 184